Penn Diabetes Drug Study Shows Promise of Personalized Medicine

Mitchell Lazar of the Perelman School of Medicine is quoted about leading a research team studying anti-diabetes drugs called thiazolidinediones (TZDs).

・ From Philadelphia Inquirer